skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Mostrar Somente
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Pembrolizumab plus chemotherapy as neoadjuvant treatment of high-risk, early-stage triple-negative breast cancer: results from the phase 1b open-label, multicohort KEYNOTE-173 study
Pembrolizumab plus chemotherapy as neoadjuvant treatment of high-risk, early-stage triple-negative breast cancer: results from the phase 1b open-label, multicohort KEYNOTE-173 study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pembrolizumab plus chemotherapy as neoadjuvant treatment of high-risk, early-stage triple-negative breast cancer: results from the phase 1b open-label, multicohort KEYNOTE-173 study

Schmid, P. ; Salgado, R. ; Park, Y.H. ; Muñoz-Couselo, E. ; Kim, S.B. ; Sohn, J. ; Im, S.-A. ; Foukakis, T. ; Kuemmel, S. ; Dent, R. ; Yin, L. ; Wang, A. ; Tryfonidis, K. ; Karantza, V. ; Cortés, J. ; Loi, S.

Annals of oncology, 2020-05, Vol.31 (5), p.569-581 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
2
Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program
Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program
Material Type:
Artigo 		Adicionar ao Meu Espaço

Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer Program

Cardoso, F. ; Bartlett, J.M.S. ; Slaets, L. ; van Deurzen, C.H.M. ; van Leeuwen-Stok, E. ; Porter, P. ; Linderholm, B. ; Hedenfalk, I. ; Schröder, C. ; Martens, J. ; Bayani, J. ; van Asperen, C. ; Murray, M. ; Hudis, C. ; Middleton, L. ; Vermeij, J. ; Punie, K. ; Fraser, J. ; Nowaczyk, M. ; Rubio, I.T. ; Aebi, S. ; Kelly, C. ; Ruddy, K.J. ; Winer, E. ; Nilsson, C. ; Lago, L. Dal ; Korde, L. ; Benstead, K. ; Bogler, O. ; Goulioti, T. ; Peric, A. ; Litière, S. ; Aalders, K.C. ; Poncet, C. ; Tryfonidis, K. ; Giordano, S.H.

Annals of oncology, 2018-02, Vol.29 (2), p.405-417 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
3
Trastuzumab versus observation for HER2 nonamplified early breast cancer with circulating tumor cells (EORTC 90091-10093, BIG 1-12, Treat CTC): a randomized phase II trial
Trastuzumab versus observation for HER2 nonamplified early breast cancer with circulating tumor cells (EORTC 90091-10093, BIG 1-12, Treat CTC): a randomized phase II trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Trastuzumab versus observation for HER2 nonamplified early breast cancer with circulating tumor cells (EORTC 90091-10093, BIG 1-12, Treat CTC): a randomized phase II trial

Ignatiadis, M. ; Litière, S. ; Rothe, F. ; Riethdorf, S. ; Proudhon, C. ; Fehm, T. ; Aalders, K. ; Forstbauer, H. ; Fasching, P.A. ; Brain, E. ; Vuylsteke, P. ; Guardiola, E. ; Lorenz, R. ; Pantel, K. ; Tryfonidis, K. ; Janni, W. ; Piccart, M. ; Sotiriou, C. ; Rack, B. ; Pierga, J.-Y.

Annals of oncology, 2018-08, Vol.29 (8), p.1777-1783 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
4
Immunohistochemical versus molecular (BluePrint and MammaPrint) subtyping of breast carcinoma. Outcome results from the EORTC 10041/BIG 3-04 MINDACT trial
Immunohistochemical versus molecular (BluePrint and MammaPrint) subtyping of breast carcinoma. Outcome results from the EORTC 10041/BIG 3-04 MINDACT trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Immunohistochemical versus molecular (BluePrint and MammaPrint) subtyping of breast carcinoma. Outcome results from the EORTC 10041/BIG 3-04 MINDACT trial

Viale, G. ; de Snoo, F. A. ; Slaets, L. ; Bogaerts, J. ; van ’t Veer, L. ; Rutgers, E. J. ; Piccart-Gebhart, M. J. ; Stork-Sloots, L. ; Glas, A. ; Russo, L. ; Dell’Orto, P. ; Tryfonidis, K. ; Litière, S. ; Cardoso, F.

Breast cancer research and treatment, 2018, Vol.167 (1), p.123-131 [Periódico revisado por pares]

New York: Springer US

Texto completo disponível

Citações Citado por
5
Small breast cancers: When and how to treat
Small breast cancers: When and how to treat
Material Type:
Artigo 		Adicionar ao Meu Espaço

Small breast cancers: When and how to treat

Tryfonidis, K ; Zardavas, D ; Cardoso, F

Cancer treatment reviews, 2014-12, Vol.40 (10), p.1129-1136 [Periódico revisado por pares]

Kidlington: Elsevier Ltd

Texto completo disponível

Citações Citado por
6
Association of BRCA1, ERCC1, RAP80, PKM2, RRM1, RRM2, TS, TSP1, and TXR1 mRNA expression levels between primary tumors and infiltrated regional lymph nodes in patients with resectable non-small cell lung cancer
Association of BRCA1, ERCC1, RAP80, PKM2, RRM1, RRM2, TS, TSP1, and TXR1 mRNA expression levels between primary tumors and infiltrated regional lymph nodes in patients with resectable non-small cell lung cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Association of BRCA1, ERCC1, RAP80, PKM2, RRM1, RRM2, TS, TSP1, and TXR1 mRNA expression levels between primary tumors and infiltrated regional lymph nodes in patients with resectable non-small cell lung cancer

Tryfonidis, K ; Papadaki, C ; Assele, S ; Lagoudaki, E ; Menis, J ; Koutsopoulos, A ; Trypaki, M ; Tsakalaki, E ; Sfakianaki, M ; Hasan, B ; Stathopoulos, E ; Georgoulias, V ; Souglakos, J

The pharmacogenomics journal, 2019-02, Vol.19 (1), p.15-24 [Periódico revisado por pares]

United States: Nature Publishing Group

Texto completo disponível

Citações Citado por
7
Corrigendum to “An association study of established breast cancer reproductive and lifestyle risk factors with tumour subtype defined by the prognostic 70-gene expression signature (MammaPrint®)” [Eur J Cancer 75 (April 2017) 5–13]
Corrigendum to “An association study of established breast cancer reproductive and lifestyle risk factors with tumour subtype defined by the prognostic 70-gene expression signature (MammaPrint®)” [Eur J Cancer 75 (April 2017) 5–13]
Material Type:
Artigo 		Adicionar ao Meu Espaço

Corrigendum to “An association study of established breast cancer reproductive and lifestyle risk factors with tumour subtype defined by the prognostic 70-gene expression signature (MammaPrint®)” [Eur J Cancer 75 (April 2017) 5–13]

Makama, M. ; Drukker, C.A. ; Rutgers, E.J.Th ; Slaets, L. ; Cardoso, F. ; Rookus, M.A. ; Tryfonidis, K. ; Van't Veer, L.J. ; Schmidt, M.K.

European journal of cancer (1990), 2018-06, Vol.96, p.131-132 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
8
An association study of established breast cancer reproductive and lifestyle risk factors with tumour subtype defined by the prognostic 70-gene expression signature (MammaPrint® )
An association study of established breast cancer reproductive and lifestyle risk factors with tumour subtype defined by the prognostic 70-gene expression signature (MammaPrint® )
Material Type:
Artigo 		Adicionar ao Meu Espaço

An association study of established breast cancer reproductive and lifestyle risk factors with tumour subtype defined by the prognostic 70-gene expression signature (MammaPrint® )

Makama, M ; Drukker, C.A ; Rutgers, E.J.Th ; Slaets, L ; Cardoso, F ; Rookus, M.A ; Tryfonidis, K ; Van't Veer, L.J ; Schmidt, M.K

European journal of cancer (1990), 2017-04, Vol.75, p.5-13 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
9
Characterisation of multifocal breast cancer using the 70-gene signature in clinical low-risk patients enrolled in the EORTC 10041/BIG 03-04 MINDACT trial
Characterisation of multifocal breast cancer using the 70-gene signature in clinical low-risk patients enrolled in the EORTC 10041/BIG 03-04 MINDACT trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Characterisation of multifocal breast cancer using the 70-gene signature in clinical low-risk patients enrolled in the EORTC 10041/BIG 03-04 MINDACT trial

Aalders, K.C ; Kuijer, A ; Straver, M.E ; Slaets, L ; Litiere, S ; Viale, G ; van't Veer, L.J ; Glas, A.M ; Delorenzi, M ; van Dalen, T ; Tryfonidis, K ; Piccart, M.J ; Cardoso, F ; Rutgers, E.J

European journal of cancer (1990), 2017-07, Vol.79, p.98-105 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
10
Correlation of BRCA1, TXR1 and TSP1 mRNA expression with treatment outcome to docetaxel-based first-line chemotherapy in patients with advanced/metastatic non-small-cell lung cancer
Correlation of BRCA1, TXR1 and TSP1 mRNA expression with treatment outcome to docetaxel-based first-line chemotherapy in patients with advanced/metastatic non-small-cell lung cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Correlation of BRCA1, TXR1 and TSP1 mRNA expression with treatment outcome to docetaxel-based first-line chemotherapy in patients with advanced/metastatic non-small-cell lung cancer

Papadaki, C ; Tsaroucha, E ; Kaklamanis, L ; Lagoudaki, E ; Trypaki, M ; Tryfonidis, K ; Mavroudis, D ; Stathopoulos, E ; Georgoulias, V ; Souglakos, J

British journal of cancer, 2011-01, Vol.104 (2), p.316-323 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (61)

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (62)
  2. Anais de Congresso  (5)
  3. Reports  (1)
  4. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.